No title
The possibilities with monoclonal antibodies to be used as drugs against several diseases is of great interest to many pharmaceutical companies. However, efficient production is hindered by advanced and difficult purification steps in the downstream processing. Chromatographic systems have proven to be a powerful methodology promoting high purity, nevertheless associated with high costs. Therefore
